Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.212/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.212 |
Version | 20230622 |
Status | active |
Date | 2023-06-22T01:00:59-04:00 |
Name | BRCA1AndBRCA2Testing |
Title | BRCA1 and BRCA2 Testing |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRCA1 and BRCA2 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRCA1 and BRCA2 testing.),(Exclusion Criteria: Excludes concepts related to BRCA1 and BRCA2 by Immune Stain.) |
No resources found
CodeSystem | |
http://www.ama-assn.org/go/cpt | Current Procedural Terminology (CPT®) |
http://www.ama-assn.org/go/cpt | Current Procedural Terminology (CPT®) |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.1444.3.212",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-07-03"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-06-22"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.212",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.3.212"
}
],
"version" : "20230622",
"name" : "BRCA1AndBRCA2Testing",
"title" : "BRCA1 and BRCA2 Testing",
"status" : "active",
"date" : "2023-06-22T01:00:59-04:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRCA1 and BRCA2 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRCA1 and BRCA2 testing.),(Exclusion Criteria: Excludes concepts related to BRCA1 and BRCA2 by Immune Stain.)",
"compose" : {
"include" : [
{
"system" : "http://www.ama-assn.org/go/cpt",
"concept" : [
{
"code" : "81162",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements)"
},
{
"code" : "81163",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis"
},
{
"code" : "81164",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)"
},
{
"code" : "81212",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; 185delAG, 5385insC, 6174delT variants"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:73d2511e-9e3c-4d55-8e8c-20b99cc0b16d",
"timestamp" : "2024-12-10T10:11:35-05:00",
"total" : 4,
"contains" : [
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "81162",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements)"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "81163",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "81164",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "81212",
"display" : "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; 185delAG, 5385insC, 6174delT variants"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.